
|Articles|July 27, 2015
Janet Freeman-Daily on Why Patients Should Attend the ASCO Meeting
Author(s)Janet Freeman-Daily
Janet Freeman-Daily on why patients should attend the annual meeting of the American Society of Clinical Oncology (ASCO).
Advertisement
We spoke with Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago. Here, Freeman-Daily discusses why patients should attend the meeting.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis
2
New Approach May Offer Stronger Treatment Effects in Metastatic Breast Cancer
3
Updated Treatment Options Improve Advanced HR+ Breast Cancer Outcomes
4
Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path
5




